Similar Posts
Critics Wonder Whether the FDA Is Too Slow to Handle a Pandemic
The FDA plays a critical role in our nation’s response to the COVID-19 pandemic. It helps decide which medicines are safe and effective to treat the disease. It evaluates the accuracy and reliability of laboratory tests. And it will play a central role in assessing potential vaccines. But will the FDA bureaucracy move with the…
There Is Nothing Wrong With Healthcare Profits
The problem with American healthcare is not the existence of greed.
The Verdict Is In—Price Gouging Harms People With Gout
The patient arrived in my clinic, their right big toe the color of a spring strawberry. The lightest touch caused exquisite pain. Fortunately, I was able to prescribe a pill (an ancient medicine, actually) and the patient was better by the next day.
Too bad that simple treatment is becoming unaffordable, through a maddening combination of greed and regulatory failure.
Antibody Tests Could Offer A False Sense of Security
A lot of hope on reopening businesses and returning to work in the U.S. hinges on COVID-19 testing and the development of treatments and a vaccine. But as the country ramps up antibody testing – analyzing blood samples for signs someone has been exposed to or infected with the coronavirus that causes COVID-19 – physician…
Time To Take Tax Breaks Away From Non-Profit Hospitals
Many wealthy nonprofit hospitals provide surprisingly little charitable care.
Pandemics and Overdoses: COVID-19 May Worsen Our Opioid Epidemic
The novel coronavirus has decimated our economy at the same time as it has directly threatened our health. As if that weren’t bad enough, the economic damage Covid-19 is causing could have an indirect impact on our health. Consider what we already know about economic downturns and opioid overdoses. A research team led by Atheendar…
